WntResearch Croissance future
Future contrôle des critères 2/6
WntResearch is forecast to grow revenue at 40.7% per annum.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
Biotechs croissance des bénéfices | 48.4% |
Taux de croissance des recettes | 40.7% |
Rendement futur des capitaux propres | n/a |
Couverture par les analystes | Low |
Dernière mise à jour | 23 Aug 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | N/A | N/A | N/A | N/A | 1 |
12/31/2025 | 94 | N/A | 77 | 76 | 1 |
12/31/2024 | N/A | N/A | -47 | -49 | 1 |
6/30/2024 | N/A | -41 | -45 | -45 | N/A |
3/31/2024 | N/A | -36 | -38 | -38 | N/A |
12/31/2023 | N/A | -32 | -31 | -31 | N/A |
9/30/2023 | N/A | -31 | -29 | -29 | N/A |
6/30/2023 | N/A | -30 | -29 | -29 | N/A |
3/31/2023 | N/A | -30 | -29 | -29 | N/A |
12/31/2022 | N/A | -31 | -36 | -36 | N/A |
9/30/2022 | N/A | -38 | -37 | -37 | N/A |
6/30/2022 | N/A | -38 | -40 | -40 | N/A |
3/31/2022 | N/A | -39 | -37 | -38 | N/A |
12/31/2021 | N/A | -36 | -31 | -31 | N/A |
9/30/2021 | N/A | -28 | -29 | -29 | N/A |
6/30/2021 | N/A | -25 | -22 | -22 | N/A |
3/31/2021 | N/A | -21 | -22 | -22 | N/A |
12/31/2020 | N/A | -22 | -23 | -22 | N/A |
9/30/2020 | N/A | -23 | -25 | -24 | N/A |
6/30/2020 | N/A | -26 | -27 | -26 | N/A |
3/31/2020 | N/A | -27 | -27 | -25 | N/A |
12/31/2019 | N/A | -25 | -29 | -28 | N/A |
9/30/2019 | N/A | -29 | -29 | -27 | N/A |
6/30/2019 | N/A | -27 | -26 | -25 | N/A |
3/31/2019 | N/A | -25 | -23 | -22 | N/A |
12/31/2018 | N/A | -24 | -18 | -17 | N/A |
9/30/2018 | N/A | -20 | -22 | -21 | N/A |
6/30/2018 | N/A | -22 | -28 | -28 | N/A |
3/31/2018 | N/A | -30 | N/A | -33 | N/A |
12/31/2017 | N/A | -35 | N/A | -35 | N/A |
9/30/2017 | N/A | -34 | N/A | -30 | N/A |
6/30/2017 | N/A | -31 | N/A | -26 | N/A |
3/31/2017 | N/A | -25 | N/A | -23 | N/A |
12/31/2016 | N/A | -20 | N/A | -19 | N/A |
9/30/2016 | -11 | -29 | N/A | -28 | N/A |
6/30/2016 | -5 | -25 | N/A | -24 | N/A |
3/31/2016 | -3 | -20 | N/A | -18 | N/A |
12/31/2015 | N/A | -18 | N/A | -18 | N/A |
9/30/2015 | 14 | -4 | N/A | -3 | N/A |
6/30/2015 | 11 | -4 | N/A | -2 | N/A |
3/31/2015 | 10 | -7 | N/A | -6 | N/A |
12/31/2014 | 8 | -7 | N/A | -8 | N/A |
9/30/2014 | 8 | -6 | N/A | -6 | N/A |
6/30/2014 | 5 | -6 | N/A | -6 | N/A |
3/31/2014 | 4 | -4 | N/A | -6 | N/A |
12/31/2013 | 5 | -4 | N/A | -4 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if WNT's forecast earnings growth is above the savings rate (1.1%).
Bénéfices vs marché: Insufficient data to determine if WNT's earnings are forecast to grow faster than the Swedish market
Croissance élevée des bénéfices: Insufficient data to determine if WNT's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: WNT's revenue (40.7% per year) is forecast to grow faster than the Swedish market (0.01% per year).
Croissance élevée des revenus: WNT's revenue (40.7% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if WNT's Return on Equity is forecast to be high in 3 years time